Free Newsletter
Protein acts as the body's quality inspector
Researchers at the Mayo Clinic have found a protein that acts as the body's quality control inspector for cells. In the normal process of cell division, there's a pause to allow for the detection of an incorrect genetic code in the DNA. When the wrong code is detected, a correction is made if possible or cyclin-dependent kinase 2 modifies another protein that orders the death of the damaged cell. The researchers say their work identifies a clear target for anti-tumor drugs.
"Quality control within dividing cells is essential because mistakes during duplication of the genetic code can lead to cancer. CDK2 is a key protein component in the cellular mechanism that leads to repair of damaged DNA," Donald Tindall, co-leader of the Mayo Clinic Cancer Center prostate cancer research program, said in a statement.
- see this release on the protein research project
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage


